Abstract: A sphere type shift control apparatus for an electronic shift system has a sphere member rotated with respect to a housing by power from a motor, and the rotation of the sphere member is restricted by holding torque of the motor, such that it is possible to implement a shift lock. Further, since a user can forcibly manually rotate the sphere member, the function of shift lock release can be implemented.

Abstract: The present disclosure relates to an optical laminate or a reddening-resistant layer. The present disclosure can provide an optical laminate that does not cause a so-called reddening phenomenon even when driven or maintained under extremely harsh conditions (e.g., very high temperature conditions), or a reddening-resistant layer applied thereto.

Abstract: A display device includes a touch panel (TP), a transparent adhesive member (TAM) on a surface of the TP, a touch printed circuit board (TPCB), and a display panel (DP) on a surface of the TAM. The TP includes a sensing portion and a pad side portion (PSP) on a side of the sensing portion. The TPCB includes a contact portion (CP) attached to a surface of the PSP. The DP includes a substrate, an optical film (OF) on a surface of the substrate, and a bending protection layer (BPL) on a side of the OF on the surface of the substrate. The surface of the PSP includes a connection area attached to the CP and a non-connection area not attached to the CP. The OF is spaced from the BPL with a gap disposed therebetween. The TAM overlaps, in a thickness direction, with the TPCB and the gap.

Abstract: A semiconductor memory device includes a memory cell array, an error correction circuit, an error log register and a control logic circuit. The memory cell array includes a plurality of memory bank arrays and each of the memory bank arrays includes a plurality of pages. The control logic circuit is configured to control the error correction circuit to perform an ECC decoding sequentially on some of the pages designated at least one access address for detecting at least one bit error, in response to a first command received from a memory controller. The control logic circuit performs an error logging operation to write page error information into the error log register and the page error information includes a number of error occurrence on each of the some pages determined from the detecting.

Abstract: Provided is a 2-cyanopyrimidin-4-yl carbamate or urea derivative or pharmaceutically acceptable salt thereof, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The 2-cyanopyrimidin-4-yl carbamate or urea derivative or pharmaceutically acceptable salt thereof selectively inhibits cathepsin K and therefore can be usefully applied for preventing or treating osteoporosis.

Abstract: Provided is a compound selected from a compound of chemical formula 1 having lysine-specific demethylase-1 (LSD1) inhibitory activity, and a tautomer, a stereoisomer, and a solvate thereof, and pharmaceutically acceptable salts of the aforementioned components. The compound is effective in the prevention or treatment of diseases caused by abnormal activation of LSD1. Also disclosed is a composition containing the compound as an active ingredient and its uses in preventing and/or treating diseases caused by abnormal activation of LSD1.

Abstract: The present invention relates to a novel pyrrolobenzodiazepine dimer compound or a pharmaceutically acceptable salt thereof, a ligand-drug conjugate compound thereof, or a composition containing the same and therapeutic use of the same as an anticancer agent. The pyrrolobenzodiazepine dimer compound according to the present invention exhibits anticancer activity equivalent to or superior to that of existing anticancer agents when being applied to a ligand-drug conjugate as a drug and administered as well as exhibits low activity and greatly diminished toxicity in the free toxin form and thus has a significantly improved therapeutic index. Hence, the pyrrolobenzodiazepine dimer compound is highly industrially applicable in that targeting of proliferative diseases such as cancer is possible, specific treatment of the proliferative diseases is possible, the drug efficacy can be maximized, and the expression of side effects can be minimized.

Abstract: Variable displacement swash plate type compressor includes casing, rotating shaft, swash plate, piston, and inclination adjustment mechanism with first flow path connecting discharge chamber with crankcase and second flow path connecting crankcase with suction chamber to adjust inclination angle of the swash plate. An orifice hole decompressing fluid passing through the second flow path is formed in the second flow path. An orifice control mechanism controlling effective flow cross-sectional area of the orifice hole is formed on the second flow path. The orifice hole and control mechanism are formed to increase differential pressure in the crankcase and suction chamber, the effective flow cross-sectional area increases, and with further differential pressure increase it becomes a second area larger than zero and less than the first area. Achieved is rapid control of refrigerant discharge amount and prevention of reduction in compressor efficiency with reduction of time to switch to the maximum mode.

Abstract: A surgical tool having an integrated orthopedic anchor and an anchor coupler are proposed. When an anchor (100) is coupled and fixed to an anchor coupling portion (220) of an anchor coupler (200), arc recesses (130a) formed in through-holes (130) and arc recesses (221a) formed at an anchor coupling portion (220) are fitted to each other, so suture insertion holes (20) aligned with holes in the anchor coupling portion (220) and having wide inlets are formed and a suture (10) may be easily connected. Further, when the anchor coupler (200) is rotated and pressed in surgery, the protruding front ends (221) separated at the anchor coupling portion (220) and protruding through the through-holes (130) at both sides of the front end of the anchor body (110) bore a bone tissue while covering an outer surface of the front end portion of the anchor (100).

Abstract: Provided is a compound represented by Formula 1 having an inhibitory activity on lysine-specific demethylase-1 (LSD1), an optical isomer, a solvate, a tautomer, or a pharmaceutically acceptable salt thereof, which is effective in preventing or treating a disease caused by abnormal activation of LSD1.

Abstract: Disclosed is a method of preparing krill oil. A method of preparing krill oil may include providing a dried krill powder; obtaining an extract after adding spirits of wine to the dried krill powder; obtaining a passing solution from which salt and cholesterol are removed by passing the extract through a column; obtaining a krill concentrate by decompression-concentrating the passing solution; and obtaining krill oil by stationarily positioning a mixture obtained by adding spirits of wine to the krill concentrate, layer-separating the stationarily positioned mixture, extracting a supernatant of the layer-separated mixture, and concentrating the extracted supernatant.

Abstract: Provided is a system and method for creating and providing a mosaic image based on an image tag-word by a mosaic service providing server, which includes: determining each tag-word for each image and classifying a plurality of images according to the determined tag-word; determining a target image among the plurality of images; providing a pixel image selection interface for selecting a pixel image for mosaicizing the determined target image based on the tag-words of the plurality of images; and creating a mosaic image for the target image based on the pixel image selected through the pixel image selection interface.

Abstract: A semiconductor memory device includes a memory cell array, an error correction circuit, an error log register and a control logic circuit. The memory cell array includes a plurality of memory bank arrays and each of the memory bank arrays includes a plurality of pages. The control logic circuit is configured to control the error correction circuit to perform an ECC decoding sequentially on some of the pages designated at least one access address for detecting at least one bit error, in response to a first command received from a memory controller. The control logic circuit performs an error logging operation to write page error information into the error log register and the page error information includes a number of error occurrence on each of the some pages determined from the detecting.

Abstract: The present invention provides: a recombinant expression vector comprising a gene encoding a porcine parvovirus VP2 protein; a recombinant plant or a recombinant insect cell transformed with the vector; and a vaccine composition for a porcine parvovirus and a composition for diagnosing porcine parvovirus, both of which contain a porcine parvovirus VP2 protein obtained from the recombinant plant or the recombinant insect cell. When the recombinant plant or recombinant insect cell of the present invention is used, the porcine parvovirus antigenic protein can be produced with high efficiency, and the porcine parvovirus antigenic protein production method using the recombinant plant or recombinant insect cell has excellent safety and stability compared with other antigen production methods.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating CMT disease, comprising histone deacetylase 6 inhibitor. The pharmaceutical composition according to the present invention has histone deacetylase 6 (HDAC6) inhibitory activity and thus is effective in preventing or treating CMT disease.

Abstract: A control valve and a variable capacity compressor having a control valve or a passage connecting the control valve and a crank chamber. A fixed orifice hole is variable which is possible by selectively opening and closing a plurality of holes depending on the operation of the compressor.

Abstract: A method for measuring displacements of an end effector passing through a load lock gate of semiconductor equipment according to an embodiment of the present disclosure includes measuring a first displacement in a vertical direction and a second displacement in a horizontal direction of the end effector while the end effector passes through the load lock gate, calculating changes in pitch and roll of the end effector based on the measured first displacement, and calculating a change in yaw of the end effector based on the measured second displacement.

Abstract: A method for determining the status of a robot according to an embodiment includes acquiring first data and second data related to an operation of the robot, acquiring a resonance frequency by analyzing the operation of the robot in a frequency region based on the first data related to the operation of the robot, acquiring a first comparison result by comparing the acquired resonance frequency with a reference resonance frequency, when the first comparison result is a threshold value or more, generating a Lissajous figure by DQ transforming a three-phase signal based on the second data related to the operation of the robot, acquiring a second comparison result by comparing the generated Lissajous figure with a reference Lissajous figure, and determining the status of the robot based on at least one of the first comparison result and the second comparison result.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating cancer, a radiosensitizer composition for treating cancer, and a health functional food for preventing or improving cancer, which comprise N-1H-benzimidazol-2-yl-3-(1H-pyrrol-1-yl) benzamide, a derivative thereof, or a pharmaceutically acceptable salt thereof as an active ingredient. The pharmaceutical composition comprising N-1H-benzimidazol-2-yl-3-(1H-pyrrol-1-yl) benzamide or a derivative thereof as an active ingredient according to the present invention arrests the mitosis of cancer cells to prevent proliferation and at the same time, to exhibit low toxicity in normal cell lines and induce apoptosis only in cancer cell lines, so it can be used as an effective anticancer agent. In addition, the N-1H-benzimidazol-2-yl-3-(1H-pyrrol-1-yl) benzamide of the present invention can increase the sensitivity of the treated cancer cells to radiation, so it can be used as a radiosensitizer composition for cancer treatment.

Abstract: A display device includes a touch panel (TP), a transparent adhesive member (TAM) on a surface of the TP, a touch printed circuit board (TPCB), and a display panel (DP) on a surface of the TAM. The TP includes a sensing portion and a pad side portion (PSP) on a side of the sensing portion. The TPCB includes a contact portion (CP) attached to a surface of the PSP. The DP includes a substrate, an optical film (OF) on a surface of the substrate, and a bending protection layer (BPL) on a side of the OF on the surface of the substrate. The surface of the PSP includes a connection area attached to the CP and a non-connection area not attached to the CP. The OF is spaced from the BPL with a gap disposed therebetween. The TAM overlaps, in a thickness direction, with the TPCB and the gap.